To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
Pregabalin BID Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.
1 other identifier
interventional
750
2 countries
103
Brief Summary
To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Nov 1999
Longer than P75 for phase_3
103 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 1999
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2005
CompletedFirst Submitted
Initial submission to the registry
August 30, 2005
CompletedFirst Posted
Study publicly available on registry
September 1, 2005
CompletedJanuary 1, 2007
December 1, 2006
August 30, 2005
December 28, 2006
Conditions
Outcome Measures
Primary Outcomes (1)
Safety Tolerability
Interventions
Eligibility Criteria
You may qualify if:
- Have received double-blind study medication and wish to receive open-label pregabalin.
You may not qualify if:
- Cannot have absence seizures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pfizerlead
Study Sites (103)
Pfizer Investigational Site
Phoenix, Arizona, 85013, United States
Pfizer Investigational Site
Tucson, Arizona, 85724, United States
Pfizer Investigational Site
Bakersfield, California, 93301, United States
Pfizer Investigational Site
Berkeley, California, 94705, United States
Pfizer Investigational Site
Concord, California, 94520, United States
Pfizer Investigational Site
Covina, California, 91723, United States
Pfizer Investigational Site
El Cajon, California, 92021, United States
Pfizer Investigational Site
Encino, California, 91436, United States
Pfizer Investigational Site
La Mesa, California, 91942, United States
Pfizer Investigational Site
Marina Del Ray, California, 90292, United States
Pfizer Investigational Site
Martinez, California, 94553, United States
Pfizer Investigational Site
Northridge, California, 91325, United States
Pfizer Investigational Site
Pinole, California, 94564, United States
Pfizer Investigational Site
Redondo Beach, California, 90277, United States
Pfizer Investigational Site
Sacramento, California, 95816, United States
Pfizer Investigational Site
Sacramento, California, 95823, United States
Pfizer Investigational Site
San Diego, California, 92120, United States
Pfizer Investigational Site
Santa Monica, California, 90404, United States
Pfizer Investigational Site
Walnut Creek, California, 94598, United States
Pfizer Investigational Site
Denver, Colorado, 80218, United States
Pfizer Investigational Site
Englewood, Colorado, 80110, United States
Pfizer Investigational Site
Danbury, Connecticut, 06810, United States
Pfizer Investigational Site
Miami, Florida, 33173, United States
Pfizer Investigational Site
Miami, Florida, 33176, United States
Pfizer Investigational Site
Orlando, Florida, 32806, United States
Pfizer Investigational Site
Tampa, Florida, 33609, United States
Pfizer Investigational Site
Atlanta, Georgia, 30322, United States
Pfizer Investigational Site
Chicago, Illinois, 60611, United States
Pfizer Investigational Site
Chicago, Illinois, 60612, United States
Pfizer Investigational Site
Chicago, Illinois, 60640, United States
Pfizer Investigational Site
Crestview Hills, Kentucky, 41017, United States
Pfizer Investigational Site
Louisville, Kentucky, 40202, United States
Pfizer Investigational Site
Ruston, Louisiana, 71270, United States
Pfizer Investigational Site
Baltimore, Maryland, 21287, United States
Pfizer Investigational Site
Detroit, Michigan, 48202-2689, United States
Pfizer Investigational Site
Golden Valley, Minnesota, 55422, United States
Pfizer Investigational Site
Minneapolis, Minnesota, 55422, United States
Pfizer Investigational Site
Jackson, Mississippi, 39216, United States
Pfizer Investigational Site
St Louis, Missouri, 63110, United States
Pfizer Investigational Site
Las Vegas, Nevada, 89102, United States
Pfizer Investigational Site
Las Vegas, Nevada, 89106, United States
Pfizer Investigational Site
Concord, New Hampshire, 03301, United States
Pfizer Investigational Site
Dover, New Hampshire, 03820, United States
Pfizer Investigational Site
New Brunswick, New Jersey, 08901, United States
Pfizer Investigational Site
New Brunswick, New Jersey, 08903, United States
Pfizer Investigational Site
Ridgewood, New Jersey, 07450, United States
Pfizer Investigational Site
Albuquerque, New Mexico, 87131-5021, United States
Pfizer Investigational Site
Albuquerque, New Mexico, 87131-5281, United States
Pfizer Investigational Site
Albuquerque, New Mexico, 87131, United States
Pfizer Investigational Site
Brooklyn, New York, 11203, United States
Pfizer Investigational Site
New York, New York, 10021, United States
Pfizer Investigational Site
The Bronx, New York, 10467, United States
Pfizer Investigational Site
Asheville, North Carolina, 28803, United States
Pfizer Investigational Site
Asheville, North Carolina, 28806, United States
Pfizer Investigational Site
Raleigh, North Carolina, 27607, United States
Pfizer Investigational Site
Winston-Salem, North Carolina, 27103, United States
Pfizer Investigational Site
Winston-Salem, North Carolina, 37103, United States
Pfizer Investigational Site
Cincinnati, Ohio, 45219, United States
Pfizer Investigational Site
Cincinnati, Ohio, 45242, United States
Pfizer Investigational Site
Columbus, Ohio, 43210, United States
Pfizer Investigational Site
Oklahoma City, Oklahoma, 73104-5068, United States
Pfizer Investigational Site
Medford, Oregon, 97504, United States
Pfizer Investigational Site
Portland, Oregon, 97201, United States
Pfizer Investigational Site
Portland, Oregon, 97209, United States
Pfizer Investigational Site
Portland, Oregon, 97210, United States
Pfizer Investigational Site
Philadelphia, Pennsylvania, 19104, United States
Pfizer Investigational Site
Philadelphia, Pennsylvania, 19107, United States
Pfizer Investigational Site
Pittsburgh, Pennsylvania, 15212, United States
Pfizer Investigational Site
Ridley Park, Pennsylvania, 19078, United States
Pfizer Investigational Site
Upland, Pennsylvania, 19013, United States
Pfizer Investigational Site
Cranston, Rhode Island, 02920, United States
Pfizer Investigational Site
Knoxville, Tennessee, 37916, United States
Pfizer Investigational Site
Memphis, Tennessee, 38103, United States
Pfizer Investigational Site
Dallas, Texas, 75216, United States
Pfizer Investigational Site
Dallas, Texas, 75230, United States
Pfizer Investigational Site
Dallas, Texas, 75243, United States
Pfizer Investigational Site
Fort Worth, Texas, 76107-2699, United States
Pfizer Investigational Site
Fort Worth, Texas, 76107, United States
Pfizer Investigational Site
Houston, Texas, 77002, United States
Pfizer Investigational Site
Houston, Texas, 77025, United States
Pfizer Investigational Site
Houston, Texas, 77030, United States
Pfizer Investigational Site
Lubbock, Texas, 79410, United States
Pfizer Investigational Site
San Antonio, Texas, 78207, United States
Pfizer Investigational Site
San Antonio, Texas, 78229, United States
Pfizer Investigational Site
Alexandria, Virginia, 22304, United States
Pfizer Investigational Site
Alexandria, Virginia, 22311, United States
Pfizer Investigational Site
Charlottesville, Virginia, 22908, United States
Pfizer Investigational Site
Roanoke, Virginia, 24014, United States
Pfizer Investigational Site
Roanoke, Virginia, 24016, United States
Pfizer Investigational Site
Sterling, Virginia, 20165, United States
Pfizer Investigational Site
Bellevue, Washington, 98004, United States
Pfizer Investigational Site
Friday Harbor, Washington, 98004, United States
Pfizer Investigational Site
Spokane, Washington, 99202, United States
Pfizer Investigational Site
Spokane, Washington, 99204, United States
Pfizer Investigational Site
Morgantown, West Virginia, 26507, United States
Pfizer Investigational Site
Marshfield, Wisconsin, 54449, United States
Pfizer Investigational Site
Milwaukee, Wisconsin, 53226, United States
Pfizer Investigational Site
Calgary, Alberta, T2N 2T9, Canada
Pfizer Investigational Site
Edmonton, Alberta, T5G 0B7, Canada
Pfizer Investigational Site
Edmonton, Alberta, T5H 3V9, Canada
Pfizer Investigational Site
Barrie, Ontario, L4M 4S5, Canada
Pfizer Investigational Site
London, Ontario, N6A 5A5, Canada
Pfizer Investigational Site
Toronto, Ontario, M5C 1R6, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pfizer CT.gov Call Center
Pfizer
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 30, 2005
First Posted
September 1, 2005
Study Start
November 1, 1999
Study Completion
July 1, 2005
Last Updated
January 1, 2007
Record last verified: 2006-12